Gara Jalqabaatti › beta-Thalassemia
Qorannoo klinikaalii beta-Thalassemia Ameerikaa Keessatti hirmaatuu
Qorannoo 15 beta-Thalassemia f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
Naannoon
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT03937817ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 40 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06364774Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 4 hanga 65 · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07599176T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 5 hanga 40 · Saalaa hunda · Haaromfame 13-Hag-2026 · NCT03653338Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 10-Ado-2026 · NCT04143724A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 2 hanga 50 · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT05736419MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 60 · Saalaa hunda · Haaromfame 06-Elb-2026 · NCT05735717Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 35 · Saalaa hunda · Haaromfame 23-Bit-2026 · NCT05477563Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 13 hanga 40 · Saalaa hunda · Haaromfame 03-Gur-2026 · NCT06647979Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Namoota walitti qabaa jiraQorannoo ilaalaa
2 Months – 60 Years · Saalaa hunda · Haaromfame 13-Ama-2026 · NCT04528355Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ama-2026 · NCT01245179Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Namoota walitti qabaa jiraSadarkaa 2
2 Months – 55 Years · Saalaa hunda · Haaromfame 15-Mud-2025 · NCT01962415AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Namoota walitti qabaa jiraSadarkaa 2
1 Day – 30 Years · Saalaa hunda · Haaromfame 08-Hag-2025 · NCT04099966A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 11-Gur-2025 · NCT06271512Study of the Role of Genetic Modifiers in Hemoglobinopathies
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 20-Bit-2024 · NCT05799118Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.